Flamel Technologies SA (FLML) was a big mover last session, as its shares rose nearly 7% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the trend for the company since April 9, as the stock is down almost 27%.
In the last 30 days, the company did not witness any estimate revision while the Zacks Consensus Estimate moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher can last.
Flamel Technologies currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Other better-ranked stocks in the medical sector include WuXi PharmaTech (Cayman) Inc. (WX), IntelliPharmaCeutics International (IPCI) and Cardiome Pharma Corp. (CRME). All three carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
INTELLIPHARMACEUTICS INTERNATION (IPCI): Free Stock Analysis Report
WUXI PHARMATECH CAYMAN INC (WX): Free Stock Analysis Report
CARDIOME PHARMA CORP ORD (CRME): Free Stock Analysis Report
FLAMEL TECHNOLOGIES ADS (FLML): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Personal Investing Ideas & Strategies